Display options
Share it on

Org Lett. 2016 Oct 07;18(19):4978-4981. doi: 10.1021/acs.orglett.6b02416. Epub 2016 Sep 22.

Exploring the Scope of Asymmetric Synthesis of β-Hydroxy-γ-lactams via Noyori-type Reductions.

Organic letters

Denis Lynch, Rebecca E Deasy, Leslie-Ann Clarke, Catherine N Slattery, U B Rao Khandavilli, Simon E Lawrence, Anita R Maguire, Nicholas A Magnus, Humphrey A Moynihan

Affiliations

  1. Department of Chemistry, Analytical and Biological Chemistry Research Facility, Synthesis and Solid State Pharmaceutical Centre, University College Cork , Cork, Ireland.
  2. Department of Chemistry and School of Pharmacy, Analytical and Biological Chemistry Research Facility, Synthesis and Solid State Pharmaceutical Centre, University College Cork , Cork, Ireland.
  3. Small Molecule Design and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  4. Eli Lilly SA, Dunderrow, Kinsale, County Cork, Ireland.

PMID: 27656907 DOI: 10.1021/acs.orglett.6b02416

Abstract

Enantio- and diastereoselective hydrogenation of β-keto-γ-lactams with a ruthenium-BINAP catalyst, involving dynamic kinetic resolution, has been employed to provide a general, asymmetric approach to β-hydroxy-γ-lactams, a structural motif common to several bioactive compounds. Full conversion to the desired β-hydroxy-γ-lactams was achieved with high diastereoselectivity (up to >98% de) by addition of catalytic HCl and LiCl, while β-branching of the ketone substituent demonstrated a pronounced effect on the modest to excellent enantioselectivity (up to 97% ee) obtained.

Publication Types